Key result
Self-reported symptoms or elevated cardiovascular risk scores identified cardiovascular disease in 30.8% of master athletes compared to 9.5% of asymptomatic controls.
Why the study?
Pre-participation cardiovascular evaluation via symptom questionnaire and cardiovascular risk-score is recommended to reduce sudden cardiac death in master athletes, but whether it predicts cardiovascular disease remained to be examined.
Does pre-participation cardiovascular evaluation by questionnaire and risk-score predict cardiovascular disease in master athletes?
Cohort (n=81)
No
Does pre-participation cardiovascular evaluation by questionnaire and risk-score predict cardiovascular disease in master athletes?
Negative findings on pre-participation cardiovascular evaluation by questionnaire and risk-score have a high negative predictive value (90%) for excluding cardiovascular disease in master athletes, potentially saving resources.
Answers are grounded in this paper and cite their sources.
Negative PCVE may support excluding low-risk master athletes from further screening to save resources; observational data leave open effects on SCD prevention.
Purpose The risk of sudden cardiac death (SCD) is increased during endurance competitive sports. Coronary artery disease (CAD) is the most common cause of SCD in master athletes ≥ 35 years old (MAs). To reduce the risk of SCD self-assessment of symptoms by questionnaire, and evaluation of cardiovascular risk-score, are recommended as pre-participation cardiovascular evaluation (PCVE). We aimed to examine whether PCVE predicts CVD in MAs with or without increased risk as measured by validated score instruments.Methods We performed a single-site observational cohort study of healthy MAs based on findings at PCVE. They were allocated in two different groups: those MAs with reported symptoms on the questionnaire and/or with elevated cardiovascular risk score were allocated to a symptom group (SG), while MAs with no symptoms, nor raised risk score were defined as control group (CG). Thereafter, all were examined with extended examinations: resting-ECG, cardiorespiratory exercise testing and echocardiography.Results Total, 81 (18 women) MAs participated in the study. There were no differences at baseline between SG (n = 39) and CG (n = 42); sex (p = 0.11), age (55.0 ± 9.8 vs. 51.9 ± 11.1 years; p = 0.18), maximal oxygen uptake (49.8 ± 7.6 vs. 51.6 ± 7.0 ml/kg/min; p = 0.26), resting heart rate (61.4 ± 12.8 vs. 60.2 ± 11.0/min; p = 0.66), training hours/week (7.0 ± 3.2 vs. 7.1 ± 3.1; p = 0.88). After further examination, sixteen (20%) MAs were found with CVD: 12 in SG, 4 in CG (p = 0.024). The negative predictive value and specificity of the PCVE were 90% and 58%, respectively.Conclusion Negative findings on PCVE by questionnaire and cardiovascular risk-score may be a strategy to exclude subjects from preparticipation screening, thus saving resources.
No takes yet. Share an insight, caveat, or question.
Grimsmo et al. (2024) conducted a cohort in Healthy master athletes (n=81). Self-reported symptoms and/or elevated cardiovascular risk score vs. No symptoms and no raised risk score was evaluated on Cardiovascular disease (CVD) detected on extended examination (p=0.024). Self-reported symptoms or elevated cardiovascular risk scores identified cardiovascular disease in 30.8% of master athletes compared to 9.5% of asymptomatic controls.
Synapse has enriched 10 related papers. Consider them for comparative context: